ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.415,79
0,12%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Evoke Pharma Inc (EVOK)

  7. Evoke Pharma Inc (EVOK) News

EVOK

Evoke Pharma (EVOK)

Evoke Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EVOK
DatumZeitQuelleÜberschriftSymbolFirma
07/06/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
31/05/202400h09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202422h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
16/05/202422h02GlobeNewswire Inc.Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:EVOKEvoke Pharma Inc
14/05/202422h58Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:EVOKEvoke Pharma Inc
14/05/202422h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EVOKEvoke Pharma Inc
14/05/202422h15GlobeNewswire Inc.Evoke Pharma Reports First Quarter 2024 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
14/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
14/05/202422h05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:EVOKEvoke Pharma Inc
14/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
17/04/202414h30GlobeNewswire Inc.Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 MedicationsNASDAQ:EVOKEvoke Pharma Inc
21/03/202421h15GlobeNewswire Inc.Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive OfficerNASDAQ:EVOKEvoke Pharma Inc
14/03/202421h05GlobeNewswire Inc.Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
07/03/202422h10GlobeNewswire Inc.Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024NASDAQ:EVOKEvoke Pharma Inc
23/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
20/02/202422h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EVOKEvoke Pharma Inc
14/02/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
14/02/202413h30GlobeNewswire Inc.Evoke Pharma Announces Closing of $7.5 Million Public OfferingNASDAQ:EVOKEvoke Pharma Inc
09/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
09/02/202423h14Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVOKEvoke Pharma Inc
09/02/202413h30GlobeNewswire Inc.Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 MillionNASDAQ:EVOKEvoke Pharma Inc
09/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVOKEvoke Pharma Inc
08/02/202412h50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
11/01/202403h38Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
04/01/202422h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
19/12/202314h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
15/12/202322h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
29/11/202315h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EVOK

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
DBI
SDXP
SDAX
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
TG
LHA
Deutsche Lufthansa
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
FX
EURJPY
Euro vs Yen
NYSE
DIS
Walt Disney
TG
RHM
Rheinmetall
USOTC
BASFY
BASF (QX)
TG
D7G
Nel ASA
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten